BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36596043)

  • 1. Primary meningeal central nervous system lymphoma: A case report and literature review.
    Chen X; Huang M; Zhang Z; Jing H; Zou Y; Bu H
    Medicine (Baltimore); 2022 Dec; 101(52):e32567. PubMed ID: 36596043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal primary central nervous system lymphoma: Case report and literature review.
    Feng L; Chen D; Zhou H; Shen C; Wang H; Sun X; Liang X; Chen L
    J Clin Neurosci; 2018 Apr; 50():16-19. PubMed ID: 29429785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Rare Case of Primary Central Nervous System Lymphoma in an Adolescent Female Treated with High-Dose Methotrexate and Rituximab-Based Chemoimmunotherapy and Consolidation Whole Brain Radiotherapy.
    Biswas A; Adhikari N; Bakhshi S; Gopinathan VR; Sharma MC
    Pediatr Neurosurg; 2019; 54(1):57-65. PubMed ID: 30669145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outcomes of primary central nervous system lymphoma patients treated with high-dose methotrexate and rituximab].
    Shiota Y; Dobashi N; Ito Y; Hosoba R; Yamauchi H; Ishii H; Nakano A; Fukushima R; Ohba R; Yahagi Y; Usui N; Yano S
    Rinsho Ketsueki; 2019; 60(2):87-92. PubMed ID: 30842385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
    Schorb E; Finke J; Ferreri AJ; Ihorst G; Mikesch K; Kasenda B; Fritsch K; Fricker H; Burger E; Grishina O; Valk E; Zucca E; Illerhaus G
    BMC Cancer; 2016 Apr; 16():282. PubMed ID: 27098429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of central nervous system lymphoma via cerebrospinal fluid cytology: a case report.
    Zhao H; Ma M; Zhang L; Zheng G; Lv H; Liu J; Li X; Song B; Zhang G
    BMC Neurol; 2019 May; 19(1):90. PubMed ID: 31064334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
    Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
    Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoma of the central nervous system originating from the septum pellucidum region: Two case reports with literature review.
    Chen D; Yan X; Lu L; Xue K; Dong X
    Medicine (Baltimore); 2023 Nov; 102(46):e35954. PubMed ID: 37986283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
    Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
    Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?
    de Pádua Covas Lage LA; Araújo Soares V; Meneguin TD; Culler HF; Reichert CO; Jacomassi MD; Reis DGC; Zerbini MCN; de Oliveira Costa R; Rocha V; Pereira J
    Radiat Oncol; 2022 Oct; 17(1):171. PubMed ID: 36273167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary natural killer/T-cell lymphoma presenting as leptomeningeal disease.
    Liao B; Kamiya-Matsuoka C; Gong Y; Chen M; Wolf BA; Fowler NH
    J Neurol Sci; 2014 Aug; 343(1-2):46-50. PubMed ID: 24880537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based expert consensus on the management of primary central nervous system lymphoma in China.
    Chen T; Liu Y; Wang Y; Chang Q; Wu J; Wang Z; Geng D; Yu JT; Li Y; Li XQ; Chen H; Zhuang D; Li J; Wang B; Jiang T; Lyu L; Song Y; Qiu X; Li W; Lin S; Zhang X; Lu D; Lei J; Chen Y; Mao Y
    J Hematol Oncol; 2022 Sep; 15(1):136. PubMed ID: 36176002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnetic resonance as initial screening diagnosis of secondary involvement of central nervous system in NHL diffuse large B cell lymphoma].
    Oliver AC; Irigoin V; Sgarbi N; Peixoto A; Turcatti P; Diaz L; Zunino J
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Jun; 75(2):67-71. PubMed ID: 30273529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Multiple Faces of Nervous System Lymphoma. Atypical Magnetic Resonance Imaging Features and Contribution of the Advanced Imaging.
    Jiménez de la Peña MD; Vicente LG; Alonso RC; Cabero SF; Suárez AM; de Vega VM
    Curr Probl Diagn Radiol; 2017; 46(2):136-145. PubMed ID: 27475832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma.
    Zhao D; Qian L; Shen J; Liu X; Mei K; Cen J; Wang Y; Li C; Ma Y
    J Cell Mol Med; 2014 Jun; 18(6):1081-6. PubMed ID: 24628986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis.
    Schmitt AM; Herbrand AK; Fox CP; Bakunina K; Bromberg JEC; Cwynarski K; Doorduijn JK; Ferreri AJM; Illerhaus G; Issa S; Schorb E; Zucca E; Hemkens LG; Schandelmaier S; Kasenda B
    Hematol Oncol; 2019 Dec; 37(5):548-557. PubMed ID: 31418878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma.
    Sun X; Liu J; Wang Y; Bai X; Chen Y; Qian J; Zhu H; Liu F; Qiu X; Sun S; Ji N; Liu Y
    Oncotarget; 2017 Jul; 8(30):49156-49164. PubMed ID: 28467782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A diagnostic challenge of primary Central nervous system lymphoma: from the eyes to the brain.
    Su M; Huang D; Sun L; Dong Z; Wu L; Yu S
    Int J Neurosci; 2021 Nov; 131(11):1139-1145. PubMed ID: 32449877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different imaging patterns of PCNSL and IVL: a case report.
    Jeon SH; Kang MK; Lee SJ; Shin BS; Kang HG
    BMC Neurol; 2019 Dec; 19(1):311. PubMed ID: 31795989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.